Market Tracker

03/28 7:45am ET

Abiomed Inc (NASDAQ:ABMD)

125.26
Delayed Data
As of Mar 27
 +0.37 / +0.30%
Today’s Change
89.74
Today|||52-Week Range
132.95
+11.16%
Year-to-Date
7 Stocks That Are Outperforming the Market
Mar 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close124.89
Today’s open123.70
Day’s range122.93 - 125.67
Volume245,891
Average volume (3 months)414,775
Market cap$5.5B
Dividend yield--
Data as of 03/27/2017

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+38.56%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+43.09%
P/E ratio117.1
Price/Sales12.92
Price/Book14.47

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+0.07+0.09%
MASIMasimo Corp+0.05+0.05%
DXCMDexCom Inc+0.78+0.94%
NUVANuVasive Inc+0.08+0.11%
Data as of 03/27/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.35
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts